Demonstrating Noninferiority of Accelerated Radiotherapy With Panitumumab vs Standard Radiotherapy With Cisplatin in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma

Samankaltaisia teoksia

• Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma
  Tekijä: Fayette, Jérôme, et al.
  Julkaistu: (2015)
• Feasibility of Cisplatin/5-Fluorouracil and Panitumumab in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck
  Tekijä: Tahara, Makoto, et al.
  Julkaistu: (2014)
• The Importance of Panitumumab in Radiotherapy Involving Head and Neck Region
  Tekijä: Cihan, Yasemin Benderli
  Julkaistu: (2018)
• Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma
  Tekijä: Grossberg, Aaron J., et al.
  Julkaistu: (2016)
• Prediction of Locoregional Control in Head and Neck Squamous Cell Carcinoma with Serial CT Perfusion during Radiotherapy
  Tekijä: Truong, M.T., et al.
  Julkaistu: (2011)